MAS1 and COVID-19: It is important to note that SARS-CoV-2 uses ACE2 to enter cells and downregulates ACE2 expression, which in turn results in the loss of the beneficial effects of the ACE2/Mas axis in the lungs, cardiovascular system, kidney, and other tissues, leading to adverse COVID-19 outcomes [33, 34].